BAM
GRTS

Belpointe Asset Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Belpointe Asset Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250
Closed -$863 – 3873
2022
Q4 		$863 Buy
+250
New +$714 ﹤0.01% 3472

Other funds holding GRTS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Belpointe Asset Management's GRTS Position: Q1 2023 in Review

Belpointe Asset Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2023, closing a stake of 250 shares — an estimated $863 sold.

Belpointe Asset Management first reported a position in GRTS in Q4 2022 and held it in 1 quarter. The position peaked at $863 in Q4 2022. 90 funds tracked by Wall St. Rank hold GRTS as of Q1 2023.

  • Belpointe Asset Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 250 Gritstone bio, Inc. Common Stock shares in Q1 2023, an estimated $863.
  • Belpointe Asset Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's Gritstone bio, Inc. Common Stock position peaked at $863 in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.